VisEn Medical Sees $5M in Expanded Series B Round

4/18/08Follow @bbuderi

Woburn, MA-based VisEn Medical, which develops fluorescence technology for non-invasive in vivo imaging, today announced it has raised $5 million in an expanded Series B financing round led by Merck Capital Ventures and Flagship Ventures. The initial Series B round, closed last November, took in $7 million.

Bob is Xconomy's founder and editor in chief. You can e-mail him at bbuderi@xconomy.com, call him at 617.500.5926. Follow @bbuderi

By posting a comment, you agree to our terms and conditions.